Citadel Advisors - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is and the CUSIP is 03152W909. A total of 3 filers reported holding AMICUS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$91,000
-53.8%
16,700
-28.3%
0.00%
Q1 2016$197,000
+84.1%
23,300
+111.8%
0.00%
Q4 2015$107,000
-58.0%
11,000
-39.6%
0.00%
Q3 2015$255,000
+56.4%
18,200
+58.3%
0.00%
Q2 2015$163,000
+45.5%
11,500
+11.7%
0.00%
Q1 2015$112,000
+103.6%
10,300
+56.1%
0.00%
Q4 2014$55,000
-21.4%
6,600
-43.6%
0.00%
Q3 2014$70,000
+1650.0%
11,700
+588.2%
0.00%
Q4 2013$4,000
-76.5%
1,700
-77.3%
0.00%
Q3 2013$17,000
+88.9%
7,500
+102.7%
0.00%
Q2 2013$9,0003,7000.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 2,020$4,664,0000.01%
GROUP ONE TRADING, L.P. 123,700$2,856,0000.01%
JPMORGAN CHASE & CO 257,500$5,946,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of AMICUS THERAPEUTICS INC shareholders